Zejing Pharmaceutical: Controlling shareholder Sheng Zelin and shareholder Ningbo Zeao have each reduced their holdings by 0.1035% and 0.9350% respectively.

In a notice from Zejing Pharmaceuticals, the controlling shareholder and actual controller Sheng Zelin reduced his holdings by 273,900 shares through centralized bidding on April 16, 2026, accounting for 0.1035% of the total share capital of the company; shareholder Ningbo Zeao reduced his holdings by 2,475,100 shares through centralized bidding from March 30 to April 15, 2026, accounting for 0.9350%. The reduction plan has been fully implemented, with Sheng Zelin now holding 49,636,600 shares, accounting for 18.7514%; Ningbo Zeao now holds 14,025,500 shares, accounting for 5.2985%.